Acromegaly in a woman presenting with diabetic ketoacidosis and insulin resistance

International Journal of Clinical Practice

Volumn 51, Issue 7, 1997, Pages 476-477

  Szeto, C C ^a   Li, K Y ^a   Ko, G T C ^a   Chow, C C ^a   Yeung, V T F ^a   Chan, J C N ^a   Cockram, C S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; GLUCOSE; INSULIN;

ACROMEGALY; ADULT; ARTICLE; BICARBONATE BLOOD LEVEL; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIABETIC KETOACIDOSIS; DIFFERENTIAL DIAGNOSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOPHYSIS ADENOMA; INSULIN RESISTANCE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSSPHENOIDAL SURGERY;

ACROMEGALY; ADENOMA; ADULT; DIABETIC KETOACIDOSIS; FEMALE; HUMANS; INSULIN RESISTANCE; PITUITARY NEOPLASMS;

EID: 0030696924     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Daughaday WH. The adenohypophysis. In: Wilson JD, Foster DW, Eds. Williams' Textbook of Endocrinology, 8th edn. Philadelphia: Saunders, 1992.
2. Abrahamson MJ. Death from diabetic ketoacidosis after cessation of octreotide in acromegaly. Lancet 1990; 336: 319-321.
3. Vidal-Cortada J, Conget-Donlo JI, Navarro-Tellez MP et al. Diabetic ketoacidosis as the first manifestation of acromegaly. Ann Med Interna 1995; 12: 76-78.
4. Luft R, Cerasi E, Hamberger CA. Studies on the pathogenesis of diabetes in acromegaly. Acta Endocrinol 1967; 56: 593-607.
5. Sharp PS, Beshyah SA, Johnston DG. Growth hormone disorders and secondary diabetes. Baillière's Clin Endocrinol Metab 1992; 6: 819-828.
6. Barrett EJ, DeFronzo RA, Bevilacqua S, Ferrannini E. Insulin resistance in diabetic ketoacidosis. Diabetes 1982; 31: 923-928.
7. Yki-Jarvinen H, Koivisto VA. Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy. J Clin Endocrinol Metab 1984; 59: 371-378.
8. Alberti KG. Role of glucagon and other hormones in development of diabetic ketoacidosis. Lancet 1975; i: 1307-1311.
9. Ginsberg HN. Investigation of insulin resistance during diabetic ketoacidosis: role of counterregulatory substances and effect of insulin therapy Metabolism 1977; 26: 1135-1146.
10. Imura H, Kkeda M, Seino Y. Significance of the measurement of plasma insulin and glucagon in the diagnosis of diabetes mellitus. Jap J Med 1977; 16: 55-56.
11. Seino Y, Taminato T, Goto Y et al. Growth hormone modulation of arginine-induced glucagon release: studies of isolated growth hormone deficiency and acromegaly. Clin Endocrinol 1978; 9: 563-570.
12. Richards CS, Uyeda K. Changes in the concentration of activation factor for phosphofructokinase in hepatocytes in response to glucose and glucagon. Biochem Biophs Res Commun 1980; 97: 1535-1540.
13. McGarry JD, Wright PH, Foster DW. Hormonal control of ketogenesis: rapid activation of hepatic ketogenic capacity in fed rats by anti-insulin serum and glucagon. J Clin Invest 1975; 55: 1202-1209.
14. Foster DW, McGarry JD. The metabolic derangements and treatment of diabetic ketoacidosis. N Engl J Med 1983, 309: 159-169.
15. Nabarro JD. Acromegaly. Clin Endocrinol 1987; 26: 481-512.
16. Gordon DA, Hill FM, Ezrin C. Acromegaly: a review of 100 cases. Can Med Ass J 1962; 87: 1106-1109.